|Articles|March 1, 2002
- Applied Clinical Trials-03-01-2002
Selecting Sites and Investigators
The system is an important part of the selection equation in CEE nations where sponsors must contract with institutions rather than investigators. Examples from Hungary offer guidelines for improving selection SOPs.
Advertisement
Articles in this issue
almost 24 years ago
Consider Geography When Choosing Investigative Sitesalmost 24 years ago
Meet the Editorial Advisory Board Francis Crawleyalmost 24 years ago
9th ACT European Summitalmost 24 years ago
Letters to the Editoralmost 24 years ago
Safety and Risk Assessment Gain Importancealmost 24 years ago
Transporting Clinical Trial Samplesalmost 24 years ago
Forward to 2004 or Back to 1984?Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
3
ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
